CYP2C19 genotypes in Germany and influence on treatment of Helicobacter pylori infection

被引：2
|
作者：
Kirsch, C
Schneider-Brachert, W
Grossmann, D
Stolte, M
Lehn, N
Miehlke, S
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80897-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [21] Zonalized therapy for Helicobacter pylori eradication depending on CYP2C19 polymorphisms
    Galvis, A. Arevalo
    Rangel, A. Trespalacios
    Regino, W. Otero
    HELICOBACTER, 2017, 22
  • [22] The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Choi, Kee Don
    Song, Ho June
    Lee, Gin Hyug
    Kim, Jin-Ho
    GUT AND LIVER, 2010, 4 (02) : 201 - 206
  • [23] The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia
    Rodrigues-Silva, Christielly
    Semedo, Agostinho Tavares
    da Silva Neri, Hiasmin Franciely
    Vianello, Rosana Pereira
    Galaviz-Hernandez, Carlos
    Sosa-Macias, Martha
    de Brito, Rodrigo Bernini
    Ghedini, Paulo Cesar
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 427 - 432
  • [24] Influence of CYP2C19 polymorphism and helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection
    Furuta, T
    Sagehashi, Y
    Shirao, N
    Sugimoto, M
    Nakamura, A
    Kodaira, M
    Kenmotsu, K
    Nagano, M
    Egashira, T
    Ueda, K
    Yoneyama, M
    Ohashi, K
    Ishizaki, T
    Hishida, A
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (06) : 564 - 573
  • [25] CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication
    Lin, Tsung-Jung
    Lee, Hsi-Chang
    Lin, Chih-Lin
    Wang, Chung-Kwe
    Chen, Kuan-Yang
    Wu, Deng-Chyang
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (12) : 514 - 520
  • [26] CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication
    Tsung-Jung Lin
    Hsi-Chang Lee
    Chih-Lin Lin
    Chung-Kwe Wang
    Kuan-Yang Chen
    Deng-Chyang Wu
    World Journal of Clinical Cases, 2018, 6 (12) : 514 - 520
  • [27] Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status
    Garza Gonzalez, E.
    Giasi Gonzalez, E.
    Martinez Vazquez, M. A.
    Perez Perez, G. I.
    Gonzalez, G. M.
    Maldonado Garza, H. J.
    Bosques Padilla, E. J.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2007, 99 (02) : 71 - 75
  • [28] IMPROVEMENTS IN HELICOBACTER PYLORI ERADICATION RATES THROUGH CLINICAL CYP2C19 GENOTYPING
    Tamura, Takashi
    Kurata, Mio
    Inoue, Shigeru
    Kondo, Takaaki
    Goto, Yasuyuki
    Kamiya, Yoshikazu
    Kawai, Sayo
    Hamajima, Nobuyuki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2011, 73 (1-2): : 25 - 31
  • [29] Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians
    Chaudhry, A. S.
    Kochhar, R.
    Kohli, K. K.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2009, 130 (04) : 437 - 443
  • [30] Effect of major CYP2C19 genetic polymorphisms on Helicobacter pylori eradication based on different treatment regimens
    Zihlif, Malek
    Bashaireh, Banan
    Rashid, Mohammed
    Almadani, Zaid
    Jarrar, Yazun
    BIOMEDICAL REPORTS, 2022, 16 (01)
12345